586 related articles for article (PubMed ID: 21654684)
41. Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.
Henriksen JR; Haug BH; Buechner J; Tømte E; Løkke C; Flaegstad T; Einvik C
BMC Dev Biol; 2011 Jan; 11():1. PubMed ID: 21194500
[TBL] [Abstract][Full Text] [Related]
42. Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.
Ribeiro D; Klarqvist MDR; Westermark UK; Oliynyk G; Dzieran J; Kock A; Savatier Banares C; Hertwig F; Johnsen JI; Fischer M; Kogner P; Lovén J; Arsenian Henriksson M
Cell Rep; 2016 Jul; 16(4):979-993. PubMed ID: 27396325
[TBL] [Abstract][Full Text] [Related]
43. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S
Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555
[TBL] [Abstract][Full Text] [Related]
44. Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo.
Johnsen JI; Segerström L; Orrego A; Elfman L; Henriksson M; Kågedal B; Eksborg S; Sveinbjörnsson B; Kogner P
Oncogene; 2008 May; 27(20):2910-22. PubMed ID: 18026138
[TBL] [Abstract][Full Text] [Related]
45. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
Molenaar JJ; Domingo-Fernández R; Ebus ME; Lindner S; Koster J; Drabek K; Mestdagh P; van Sluis P; Valentijn LJ; van Nes J; Broekmans M; Haneveld F; Volckmann R; Bray I; Heukamp L; Sprüssel A; Thor T; Kieckbusch K; Klein-Hitpass L; Fischer M; Vandesompele J; Schramm A; van Noesel MM; Varesio L; Speleman F; Eggert A; Stallings RL; Caron HN; Versteeg R; Schulte JH
Nat Genet; 2012 Nov; 44(11):1199-206. PubMed ID: 23042116
[TBL] [Abstract][Full Text] [Related]
46. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
[TBL] [Abstract][Full Text] [Related]
47. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.
Shu J; Xia Z; Li L; Liang ET; Slipek N; Shen D; Foo J; Subramanian S; Steer CJ
RNA Biol; 2012 Oct; 9(10):1275-87. PubMed ID: 22995834
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
49. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
50. Targeting MYCN in neuroblastoma by BET bromodomain inhibition.
Puissant A; Frumm SM; Alexe G; Bassil CF; Qi J; Chanthery YH; Nekritz EA; Zeid R; Gustafson WC; Greninger P; Garnett MJ; McDermott U; Benes CH; Kung AL; Weiss WA; Bradner JE; Stegmaier K
Cancer Discov; 2013 Mar; 3(3):308-23. PubMed ID: 23430699
[TBL] [Abstract][Full Text] [Related]
51. Expression patterns of microRNAs are altered in hypoxic human neuroblastoma cells.
Yamagata T; Yoshizawa J; Ohashi S; Yanaga K; Ohki T
Pediatr Surg Int; 2010 Dec; 26(12):1179-84. PubMed ID: 20809117
[TBL] [Abstract][Full Text] [Related]
52. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
54. A cell-based high-throughput screen addressing 3'UTR-dependent regulation of the MYCN gene.
Sidarovich V; Adami V; Quattrone A
Mol Biotechnol; 2014 Jul; 56(7):631-43. PubMed ID: 24515800
[TBL] [Abstract][Full Text] [Related]
55. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
Cheung IY; Farazi TA; Ostrovnaya I; Xu H; Tran H; Mihailovic A; Tuschl T; Cheung NK
Genes Chromosomes Cancer; 2014 Oct; 53(10):803-14. PubMed ID: 24898736
[TBL] [Abstract][Full Text] [Related]
56. Human neuroblastoma cells with MYCN amplification are selectively resistant to oxidative stress by transcriptionally up-regulating glutamate cysteine ligase.
Veas-Perez de Tudela M; Delgado-Esteban M; Cuende J; Bolaños JP; Almeida A
J Neurochem; 2010 May; 113(4):819-25. PubMed ID: 20180881
[TBL] [Abstract][Full Text] [Related]
57. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
Chayka O; Corvetta D; Dews M; Caccamo AE; Piotrowska I; Santilli G; Gibson S; Sebire NJ; Himoudi N; Hogarty MD; Anderson J; Bettuzzi S; Thomas-Tikhonenko A; Sala A
J Natl Cancer Inst; 2009 May; 101(9):663-77. PubMed ID: 19401549
[TBL] [Abstract][Full Text] [Related]
58. RNA N
Cheng J; Xu L; Deng L; Xue L; Meng Q; Wei F; Wang J
Sci Rep; 2020 Aug; 10(1):13624. PubMed ID: 32788584
[TBL] [Abstract][Full Text] [Related]
59. MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.
Beckers A; Van Peer G; Carter DR; Mets E; Althoff K; Cheung BB; Schulte JH; Mestdagh P; Vandesompele J; Marshall GM; De Preter K; Speleman F
Oncotarget; 2015 Mar; 6(7):5204-16. PubMed ID: 25294817
[TBL] [Abstract][Full Text] [Related]
60. A combined experimental and computational study on peptide nucleic acid (PNA) analogues of tumor suppressive miRNA-34a.
Piacenti V; Langella E; Autiero I; Nolan JC; Piskareva O; Adamo MFA; Saviano M; Moccia M
Bioorg Chem; 2019 Oct; 91():103165. PubMed ID: 31419642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
